Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 11,395,000 | 10,598,000 | 10,541,000 | 10,345,000 | 10,886,000 |
| Cost of Goods | 6,573,000 | 6,270,000 | 6,194,000 | 6,140,000 | 6,493,000 |
| Gross Profit | 4,822,000 | 4,328,000 | 4,347,000 | 4,205,000 | 4,393,000 |
| Operating Expenses | 2,805,000 | 2,489,000 | 2,527,000 | 2,543,000 | 2,539,000 |
| Operating Income | 2,016,000 | 1,838,000 | 1,820,000 | 1,663,000 | 1,854,000 |
| Interest Expense | 317,000 | 356,000 | 354,000 | 363,000 | 390,000 |
| Other Income | 275,000 | 246,000 | 215,000 | 312,000 | 275,000 |
| Pre-tax Income | 1,974,000 | 1,728,000 | 1,681,000 | 1,612,000 | 1,739,000 |
| Income Tax | 149,000 | 99,000 | 128,000 | 281,000 | 133,000 |
| Net Income Continuous | 1,825,000 | 1,629,000 | 1,553,000 | 1,331,000 | 1,606,000 |
| Minority Interests | -7,000 | N/A | 6,000 | 4,000 | -24,000 |
| Net Income | $1,832,000 | $1,629,000 | $1,547,000 | $1,327,000 | $1,630,000 |
| EPS Basic Total Ops | 4.80 | 4.26 | 4.05 | 3.47 | 4.21 |
| EPS Basic Continuous Ops | 4.78 | 4.26 | 4.07 | 3.48 | 4.16 |
| EPS Diluted Total Ops | 4.78 | 4.25 | 4.04 | 3.46 | 4.20 |
| EPS Diluted Continuous Ops | 4.79 | 4.24 | 4.05 | 3.47 | 4.14 |
| EPS Diluted Before Non-Recurring Items | 6.10 | 5.28 | 5.37 | N/A | N/A |
| EBITDA(a) | $2,759,000 | $2,578,000 | $2,611,000 | $2,498,000 | $2,693,000 |